PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference

Rhea-AI Summary

PMV Pharmaceuticals (Nasdaq: PMVP) announced that its CEO, David H. Mack, will join a fireside chat at the Goldman Sachs Global Healthcare Conference from June 14-16, 2022, in California. The chat is scheduled for June 14 at 1:20 p.m. PDT. PMV Pharma focuses on precision oncology, developing therapies targeting p53 mutations, which occur in about half of all cancers. The company will also conduct one-on-one meetings with institutional investors during the event. For more details, visit www.pmvpharma.com.

CRANBURY, N.J., June 08, 2022 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP; “PMV Pharma”), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President & Chief Executive Officer of PMV Pharmaceuticals, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference taking place in Ranchos Palos Verdes, California June 14-16, 2022.

The company will also be available to meet one-on-one with institutional investors at the conference.

Details on the fireside chat can be found below.

Goldman Sachs Global Healthcare Conference

Date:	Tuesday, June 14, 2022
Time:	1:20 p.m.-1:55p.m. PDT

About PMV Pharma

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey. For more information, please visit www.pmvpharma.com.

Contacts

Investor Contact:

Winston Kung
PMV Pharmaceuticals, Inc.
investors@pmvpharma.com

Media Contact:

Kathy Vincent
Greig Communications
kathy@greigcommunications.com

FAQ

When is the Goldman Sachs Global Healthcare Conference for PMV Pharmaceuticals?

The conference takes place from June 14-16, 2022.

What time will PMV Pharmaceuticals' CEO speak at the conference?

David H. Mack, CEO, will speak on June 14 at 1:20 p.m. PDT.

Where will the Goldman Sachs Global Healthcare Conference be held?

The conference will be held in Ranchos Palos Verdes, California.

What is the primary focus of PMV Pharmaceuticals?

PMV Pharmaceuticals specializes in developing small molecule, tumor-agnostic therapies targeting p53 mutations.

How can investors learn more about PMV Pharmaceuticals?

Investors can visit PMV Pharma's website at www.pmvpharma.com for more information.